Go Pro

NeuroPace (NPCE) 10K Form and Latest SEC Filings 2026

NeuroPace logo
$14.28 +0.13 (+0.92%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$14.27 -0.01 (-0.07%)
As of 09/18/2026 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest NeuroPace SEC Filings & Recent Activity

NeuroPace (NASDAQ:NPCE) has submitted 244+ documents to the U.S. Securities and Exchange Commission (SEC) since 2020. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in NeuroPace's financial statements. The most recent filing was a Form 4 submitted on September 4, 2026.

Form 4
NeuroPace Inc Reports Ownership Change on Sep. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
NeuroPace Files Quarterly Report on Aug. 11, 2026

The 10-Q contains NeuroPace's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

NeuroPace SEC Filing History

Browse NeuroPace's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
09/04/2026 4:42 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2026 3:45 PM
First Light Asset Management, LLC (1600004) Filed by
NeuroPace (1528287) Subject
Form SCHEDULE 13G/A
08/28/2026 4:03 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2026 4:04 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2026 4:40 PM
NeuroPace (1528287) Subject
ORBIMED ADVISORS LLC (1055951) Filed by
Form SCHEDULE 13G/A
08/11/2026 3:33 PM
NeuroPace (1528287) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2026 3:12 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:32 PM
Kumar Rakhi (1856296) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:33 PM
Fischer Frank M (1297260) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 3:34 PM
Geiger Uri (1467361) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 3:54 PM
NeuroPace (1528287) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2026 4:09 PM
Andrade Lisa (1595202) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:09 PM
NeuroPace (1528287) Issuer
Ryan Renee (1855576) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:10 PM
Kumar Rakhi (1856296) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:10 PM
Geiger Uri (1467361) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:10 PM
Fischer Frank M (1297260) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2026 4:13 PM
Huennekens R Scott (1365493) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 3:03 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2026 3:42 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 3:51 PM
NeuroPace (1528287) Issuer
Williams Patrick F. (1562229) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 3:45 PM
NeuroPace (1528287) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2026 3:07 PM
NeuroPace (1528287) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2026 3:05 PM
NeuroPace (1528287) Filer
Form DEF 14A
04/21/2026 3:06 PM
NeuroPace (1528287) Filer
Form DEFA14A
04/21/2026 3:07 PM
NeuroPace (1528287) Filer
Form ARS
03/25/2026 3:20 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 3:45 PM
LACOB JOSEPH (1215490) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 3:47 PM
Geiger Uri (1467361) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 3:41 PM
Fischer Frank M (1297260) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 3:42 PM
Kumar Rakhi (1856296) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 3:41 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 3:09 PM
NeuroPace (1528287) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 3:46 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 11:51 AM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 4:31 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:15 PM
Fischer Frank M (1297260) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:15 PM
Geiger Uri (1467361) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:15 PM
Kumar Rakhi (1856296) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2025 3:15 PM
LACOB JOSEPH (1215490) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 3:26 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 3:30 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
The trade I’ve been waiting for since 2011 (Ad)

Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.tc pixel

Watch the free video briefing and learn the No. 1 trade to leverage rising gold
12/01/2025 3:15 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2025 3:15 PM
Becker Joel (1533175) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2025 3:57 PM
Morrell Martha (1855616) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 3:10 PM
NeuroPace (1528287) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2025 6:30 PM
Fischer Frank M (1297260) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2025 6:30 PM
Kumar Rakhi (1856296) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2025 6:30 PM
LACOB JOSEPH (1215490) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2025 6:30 PM
Geiger Uri (1467361) Reporting
NeuroPace (1528287) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

NeuroPace SEC Filings - Frequently Asked Questions

NeuroPace (NPCE) has submitted 244+ filings to the SEC since 2020. You can browse the complete history or filter by form type using the tools above.

NeuroPace's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on NeuroPace's financial statements page.

The most recent filing was a Form 4 submitted on September 4, 2026. This was an insider ownership change filed by 4 - NeuroPace Inc (0001528287) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:NPCE are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 9/4/2026. New filings are added as they're published.
From Our Partners